Dependence of NPM1-mutated AML cells on epigenetic machinery for HOX regulation [92] provides the rationale for using inhibitors of KMT2A-menin protein interaction [93, 94] (Fig. 2; Table 2). The gene discussed is KMT2A; the disease is acute myeloid leukemia.